BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 33583594)

  • 1. Diminished ovarian reserve is associated with reduced euploid rates via preimplantation genetic testing for aneuploidy independently from age: evidence for concomitant reduction in oocyte quality with quantity.
    Jaswa EG; McCulloch CE; Simbulan R; Cedars MI; Rosen MP
    Fertil Steril; 2021 Apr; 115(4):966-973. PubMed ID: 33583594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diagnosis of diminished ovarian reserve does not impact embryo aneuploidy or live birth rates compared to patients with normal ovarian reserve.
    Fouks Y; Penzias A; Neuhausser W; Vaughan D; Sakkas D
    Fertil Steril; 2022 Sep; 118(3):504-512. PubMed ID: 35820943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
    Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
    Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher rates of aneuploidy in blastocysts and higher risk of no embryo transfer in recurrent pregnancy loss patients with diminished ovarian reserve undergoing in vitro fertilization.
    Shahine LK; Marshall L; Lamb JD; Hickok LR
    Fertil Steril; 2016 Oct; 106(5):1124-1128. PubMed ID: 27371114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation.
    Ubaldi FM; Capalbo A; Vaiarelli A; Cimadomo D; Colamaria S; Alviggi C; Trabucco E; Venturella R; Vajta G; Rienzi L
    Fertil Steril; 2016 Jun; 105(6):1488-1495.e1. PubMed ID: 27020168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reproductive potential of vitrified-warmed euploid embryos declines following repeated uterine transfers.
    Almohammadi A; Choucair F; El Taha L; Burjaq H; Albader M; Cavanillas AB; Awwad JT
    Reprod Biol Endocrinol; 2024 Feb; 22(1):23. PubMed ID: 38350949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rationale for biopsying embryos reaching the morula stage on Day 6 in women undergoing preimplantation genetic testing for aneuploidy.
    Irani M; Zaninovic N; Canon C; O'Neill C; Gunnala V; Zhan Q; Palermo G; Reichman D; Rosenwaks Z
    Hum Reprod; 2018 May; 33(5):935-941. PubMed ID: 29546326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the reproductive potential of day 7 euploid embryos?
    Hernandez-Nieto C; Lee JA; Slifkin R; Sandler B; Copperman AB; Flisser E
    Hum Reprod; 2019 Sep; 34(9):1697-1706. PubMed ID: 31398251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worth the wait? Day 7 blastocysts have lower euploidy rates but similar sustained implantation rates as Day 5 and Day 6 blastocysts.
    Tiegs AW; Sun L; Patounakis G; Scott RT
    Hum Reprod; 2019 Sep; 34(9):1632-1639. PubMed ID: 31402381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking past the appearance: a comprehensive description of the clinical contribution of poor-quality blastocysts to increase live birth rates during cycles with aneuploidy testing.
    Cimadomo D; Soscia D; Vaiarelli A; Maggiulli R; Capalbo A; Ubaldi FM; Rienzi L
    Hum Reprod; 2019 Jul; 34(7):1206-1214. PubMed ID: 31247100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle.
    Cimadomo D; Vaiarelli A; Colamaria S; Trabucco E; Alviggi C; Venturella R; Alviggi E; Carmelo R; Rienzi L; Ubaldi FM
    Hum Reprod; 2018 Aug; 33(8):1442-1448. PubMed ID: 29912374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive genetics laboratory may impact euploid blastocyst and live birth rates: a comparison of 4 national laboratories' PGT-A results from vitrified donor oocytes.
    Bardos J; Kwal J; Caswell W; Jahandideh S; Stratton M; Tucker M; DeCherney A; Devine K; Hill M; O'Brien JE
    Fertil Steril; 2023 Jan; 119(1):29-35. PubMed ID: 36460523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles.
    Mazzilli R; Cimadomo D; Vaiarelli A; Capalbo A; Dovere L; Alviggi E; Dusi L; Foresta C; Lombardo F; Lenzi A; Tournaye H; Alviggi C; Rienzi L; Ubaldi FM
    Fertil Steril; 2017 Dec; 108(6):961-972.e3. PubMed ID: 28985908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The accumulation of vitrified oocytes is a strategy to increase the number of euploid available blastocysts for transfer after preimplantation genetic testing.
    Chamayou S; Sicali M; Alecci C; Ragolia C; Liprino A; Nibali D; Storaci G; Cardea A; Guglielmino A
    J Assist Reprod Genet; 2017 Apr; 34(4):479-486. PubMed ID: 28070710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).
    Palmerola KL; Vitez SF; Amrane S; Fischer CP; Forman EJ
    J Assist Reprod Genet; 2019 Jan; 36(1):153-157. PubMed ID: 30362056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preimplantation genetic diagnosis for aneuploidy testing in women older than 44 years: a multicenter experience.
    Ubaldi FM; Cimadomo D; Capalbo A; Vaiarelli A; Buffo L; Trabucco E; Ferrero S; Albani E; Rienzi L; Levi Setti PE
    Fertil Steril; 2017 May; 107(5):1173-1180. PubMed ID: 28433373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor oocyte recipients do not benefit from preimplantation genetic testing for aneuploidy to improve pregnancy outcomes.
    Doyle N; Gainty M; Eubanks A; Doyle J; Hayes H; Tucker M; Devine K; DeCherney A; Levy M; Jahandideh S; Hill M
    Hum Reprod; 2020 Nov; 35(11):2548-2555. PubMed ID: 33057600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.
    La Marca A; Minasi MG; Sighinolfi G; Greco P; Argento C; Grisendi V; Fiorentino F; Greco E
    Fertil Steril; 2017 Nov; 108(5):777-783.e2. PubMed ID: 28987789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preimplantation genetic testing for aneuploidy in poor ovarian responders with four or fewer oocytes retrieved.
    Deng J; Hong HY; Zhao Q; Nadgauda A; Ashrafian S; Behr B; Lathi RB
    J Assist Reprod Genet; 2020 May; 37(5):1147-1154. PubMed ID: 32285297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.